KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Capital Employed (2018 - 2025)

Historic Return on Capital Employed for Aquestive Therapeutics (AQST) over the last 8 years, with Q3 2025 value amounting to 0.54%.

  • Aquestive Therapeutics' Return on Capital Employed fell 3300.0% to 0.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.54%, marking a year-over-year decrease of 3300.0%. This contributed to the annual value of 0.51% for FY2024, which is 1200.0% down from last year.
  • Per Aquestive Therapeutics' latest filing, its Return on Capital Employed stood at 0.54% for Q3 2025, which was down 3300.0% from 0.7% recorded in Q2 2025.
  • In the past 5 years, Aquestive Therapeutics' Return on Capital Employed ranged from a high of 0.14% in Q2 2024 and a low of 2.82% during Q4 2022
  • For the 5-year period, Aquestive Therapeutics' Return on Capital Employed averaged around 0.98%, with its median value being 0.83% (2021).
  • In the last 5 years, Aquestive Therapeutics' Return on Capital Employed plummeted by -19900bps in 2022 and then surged by 24400bps in 2023.
  • Over the past 5 years, Aquestive Therapeutics' Return on Capital Employed (Quarter) stood at 0.83% in 2021, then tumbled by -239bps to 2.82% in 2022, then surged by 87bps to 0.38% in 2023, then rose by 6bps to 0.35% in 2024, then tumbled by -53bps to 0.54% in 2025.
  • Its Return on Capital Employed stands at 0.54% for Q3 2025, versus 0.7% for Q2 2025 and 0.49% for Q1 2025.